Single Dose Escalation Trial to Evaluate the Safety, Tolerability Pharmacokinetics and Pharmacodynamics of GSK3050002

Clinical trial NCT01984047 · COMPLETED

Trial details

NCT number: NCT01984047
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Colitis, Ulcerative

Start date: 2014-01-10
Primary completion: 2015-02-23
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.